PISCATAWAY, N.J. — Camber Pharmaceuticals on Tuesday announced the launch of rizatriptan benzoate tablets in 5- and 10-mg dosage strengths. The drug is the generic version of Maxalt tablets from Merck and Co.
Rizatriptan benzoate tablets — indicated to treat migraine headaches — are available in 18-count blister packs for both dosage strengths.